Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
243 hedge funds and large institutions have $3.68B invested in Abiomed Inc in 2015 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 81 increasing their positions, 94 reducing their positions, and 32 closing their positions.
154% more call options, than puts
Call options by funds: $13M | Put options by funds: $5.11M
53% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 32
39% more capital invested
Capital invested by funds: $2.64B → $3.68B (+$1.03B)
7% more funds holding
Funds holding: 227 → 243 (+16)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
14% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 94
Top Buyers
Top Sellers
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$74.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$47.6M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$15.8M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$15.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.1M |
ABMD Hedge Fund Activity: Q3 2015 in Review
243 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2015, worth a combined $3.68B — up 39% from $2.64B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new ABMD positions and 32 closed out — a net gain of 17 holders — while 81 added to existing stakes and 94 trimmed.
The largest buyer was Oak Ridge Investments, opening a new position worth an estimated $52.7M. The largest seller was William Blair & Company, cutting an estimated $74.9M.
- 243 institutional investors held Abiomed Inc (ABMD) as of Q3 2015, up from 227 in Q2 2015.
- Funds reported $3.68B of Abiomed Inc stock for Q3 2015, up 39% quarter-over-quarter.
- 49 funds opened new Abiomed Inc positions in Q3 2015 and 32 closed out, a net change of +17 holders.
- The largest Abiomed Inc buyer in Q3 2015 was Oak Ridge Investments, an estimated $52.7M added.
- The largest Abiomed Inc seller in Q3 2015 was William Blair & Company, an estimated $74.9M sold.
Based on aggregated 13F filings for Q3 2015.